1,878 research outputs found
Recommended from our members
Predicting peptides binding to MHC class II molecules using multi-objective evolutionary algorithms
<p>Abstract</p> <p>Background</p> <p>Peptides binding to Major Histocompatibility Complex (MHC) class II molecules are crucial for initiation and regulation of immune responses. Predicting peptides that bind to a specific MHC molecule plays an important role in determining potential candidates for vaccines. The binding groove in class II MHC is open at both ends, allowing peptides longer than 9-mer to bind. Finding the consensus motif facilitating the binding of peptides to a MHC class II molecule is difficult because of different lengths of binding peptides and varying location of 9-mer binding core. The level of difficulty increases when the molecule is promiscuous and binds to a large number of low affinity peptides.</p> <p>In this paper, we propose two approaches using multi-objective evolutionary algorithms (MOEA) for predicting peptides binding to MHC class II molecules. One uses the information from both binders and non-binders for self-discovery of motifs. The other, in addition, uses information from experimentally determined motifs for guided-discovery of motifs.</p> <p>Results</p> <p>The proposed methods are intended for finding peptides binding to MHC class II I-A<sup>g7 </sup>molecule – a promiscuous binder to a large number of low affinity peptides. Cross-validation results across experiments on two motifs derived for I-A<sup>g7 </sup>datasets demonstrate better generalization abilities and accuracies of the present method over earlier approaches. Further, the proposed method was validated and compared on two publicly available benchmark datasets: (1) an ensemble of qualitative HLA-DRB1*0401 peptide data obtained from five different sources, and (2) quantitative peptide data obtained for sixteen different alleles comprising of three mouse alleles and thirteen HLA alleles. The proposed method outperformed earlier methods on most datasets, indicating that it is well suited for finding peptides binding to MHC class II molecules.</p> <p>Conclusion</p> <p>We present two MOEA-based algorithms for finding motifs, one for self-discovery and the other for guided-discovery by experimentally determined motifs, and thereby predicting binding peptides to I-A<sup>g7 </sup>molecule. Our experiments show that the proposed MOEA-based algorithms are better than earlier methods in predicting binding sites not only on I-A<sup>g7 </sup>but also on most alleles of class II MHC benchmark datasets. This shows that our methods could be applicable to find binding motifs in a wide range of alleles.</p
Maximum n-times Coverage for Vaccine Design
We introduce the maximum -times coverage problem that selects overlays
to maximize the summed coverage of weighted elements, where each element must
be covered at least times. We also define the min-cost -times coverage
problem where the objective is to select the minimum set of overlays such that
the sum of the weights of elements that are covered at least times is at
least . Maximum -times coverage is a generalization of the multi-set
multi-cover problem, is NP-complete, and is not submodular. We introduce two
new practical solutions for -times coverage based on integer linear
programming and sequential greedy optimization. We show that maximum -times
coverage is a natural way to frame peptide vaccine design, and find that it
produces a pan-strain COVID-19 vaccine design that is superior to 29 other
published designs in predicted population coverage and the expected number of
peptides displayed by each individual's HLA molecules.Comment: 10 pages, 5 figure
GPS-MBA: Computational Analysis of MHC Class II Epitopes in Type 1 Diabetes
As a severe chronic metabolic disease and autoimmune disorder, type 1 diabetes (T1D) affects millions of people world-wide. Recent advances in antigen-based immunotherapy have provided a great opportunity for further treating T1D with a high degree of selectivity. It is reported that MHC class II I-Ag7 in the non-obese diabetic (NOD) mouse and human HLA-DQ8 are strongly linked to susceptibility to T1D. Thus, the identification of new I-Ag7 and HLA-DQ8 epitopes would be of great help to further experimental and biomedical manipulation efforts. In this study, a novel GPS-MBA (MHC Binding Analyzer) software package was developed for the prediction of I-Ag7 and HLA-DQ8 epitopes. Using experimentally identified epitopes as the training data sets, a previously developed GPS (Group-based Prediction System) algorithm was adopted and improved. By extensive evaluation and comparison, the GPS-MBA performance was found to be much better than other tools of this type. With this powerful tool, we predicted a number of potentially new I-Ag7 and HLA-DQ8 epitopes. Furthermore, we designed a T1D epitope database (TEDB) for all of the experimentally identified and predicted T1D-associated epitopes. Taken together, this computational prediction result and analysis provides a starting point for further experimental considerations, and GPS-MBA is demonstrated to be a useful tool for generating starting information for experimentalists. The GPS-MBA is freely accessible for academic researchers at: http://mba.biocuckoo.org
Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan
CD4 positive T helper cells control many aspects of specific immunity. These cells are specific for peptides derived from protein antigens and presented by molecules of the extremely polymorphic major histocompatibility complex (MHC) class II system. The identification of peptides that bind to MHC class II molecules is therefore of pivotal importance for rational discovery of immune epitopes. HLA-DR is a prominent example of a human MHC class II. Here, we present a method, NetMHCIIpan, that allows for pan-specific predictions of peptide binding to any HLA-DR molecule of known sequence. The method is derived from a large compilation of quantitative HLA-DR binding events covering 14 of the more than 500 known HLA-DR alleles. Taking both peptide and HLA sequence information into account, the method can generalize and predict peptide binding also for HLA-DR molecules where experimental data is absent. Validation of the method includes identification of endogenously derived HLA class II ligands, cross-validation, leave-one-molecule-out, and binding motif identification for hitherto uncharacterized HLA-DR molecules. The validation shows that the method can successfully predict binding for HLA-DR molecules-even in the absence of specific data for the particular molecule in question. Moreover, when compared to TEPITOPE, currently the only other publicly available prediction method aiming at providing broad HLA-DR allelic coverage, NetMHCIIpan performs equivalently for alleles included in the training of TEPITOPE while outperforming TEPITOPE on novel alleles. We propose that the method can be used to identify those hitherto uncharacterized alleles, which should be addressed experimentally in future updates of the method to cover the polymorphism of HLA-DR most efficiently. We thus conclude that the presented method meets the challenge of keeping up with the MHC polymorphism discovery rate and that it can be used to sample the MHC "space," enabling a highly efficient iterative process for improving MHC class II binding predictions
Leveraging Machine Learning Models for Peptide-Protein Interaction Prediction
Peptides play a pivotal role in a wide range of biological activities through
participating in up to 40% protein-protein interactions in cellular processes.
They also demonstrate remarkable specificity and efficacy, making them
promising candidates for drug development. However, predicting peptide-protein
complexes by traditional computational approaches, such as Docking and
Molecular Dynamics simulations, still remains a challenge due to high
computational cost, flexible nature of peptides, and limited structural
information of peptide-protein complexes. In recent years, the surge of
available biological data has given rise to the development of an increasing
number of machine learning models for predicting peptide-protein interactions.
These models offer efficient solutions to address the challenges associated
with traditional computational approaches. Furthermore, they offer enhanced
accuracy, robustness, and interpretability in their predictive outcomes. This
review presents a comprehensive overview of machine learning and deep learning
models that have emerged in recent years for the prediction of peptide-protein
interactions.Comment: 46 pages, 10 figure
An overview of bioinformatics tools for epitope prediction: Implications on vaccine development
AbstractExploitation of recombinant DNA and sequencing technologies has led to a new concept in vaccination in which isolated epitopes, capable of stimulating a specific immune response, have been identified and used to achieve advanced vaccine formulations; replacing those constituted by whole pathogen-formulations. In this context, bioinformatics approaches play a critical role on analyzing multiple genomes to select the protective epitopes in silico. It is conceived that cocktails of defined epitopes or chimeric protein arrangements, including the target epitopes, may provide a rationale design capable to elicit convenient humoral or cellular immune responses. This review presents a comprehensive compilation of the most advantageous online immunological software and searchable, in order to facilitate the design and development of vaccines. An outlook on how these tools are supporting vaccine development is presented. HIV and influenza have been taken as examples of promising developments on vaccination against hypervariable viruses. Perspectives in this field are also envisioned
- …